Active Ingredient History
Inclacumab (LC1004-002) (INN) is a human monoclonal antibody designed for the treatment of cardiovascular disease. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Anemia, Sickle Cell (Phase 3)
Arterial Occlusive Diseases (Phase 3)
Healthy Volunteers (Phase 1)
Myocardial Infarction (Phase 2)
Pain (Phase 3)
Peripheral Arterial Disease (Phase 1)
Vascular Grafting (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue